Literature DB >> 8907349

Congenital toxoplasmosis complicated by central diabetes insipidus in an infant with Down syndrome.

R Yamakawa1, Y Yamashita, A Yano, J Morita, H Kato.   

Abstract

We describe an infant with the unusual combination of Down syndrome, congenital toxoplasmosis, and central diabetes insipidus. Hydrocephalus was documented by fetal ultrasonography at 36 weeks' gestation. He developed central diabetes insipidus as a neonate, followed by interstitial pneumonia, anemia, and hepatosplenomegaly. The patient's serum titer for Toxoplasma-specific IgM (ELISA) at 37 days after delivery was negative, but the Toxoplasma SAG1 gene was detected from the cells of the cerebrospinal fluid on the same day using the polymerase chain reaction (PCR) method. Congenital toxoplasmosis can contribute to the development of central diabetes insipidus in infants. PCR was useful in diagnosing congenital toxoplasmosis rapidly and accurately.

Entities:  

Mesh:

Year:  1996        PMID: 8907349     DOI: 10.1016/0387-7604(95)00099-2

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  5 in total

Review 1.  Polymerase chain reaction in the diagnosis of congenital toxoplasmosis: more than two decades of development and evaluation.

Authors:  Rashad Abdul-Ghani
Journal:  Parasitol Res       Date:  2011-01-11       Impact factor: 2.289

Review 2.  Why prevent, diagnose and treat congenital toxoplasmosis?

Authors:  Rima McLeod; Francois Kieffer; Mari Sautter; Tiffany Hosten; Herve Pelloux
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-03       Impact factor: 2.743

3.  Toxoplasmosis--a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries.

Authors:  Jaroslav Flegr; Joseph Prandota; Michaela Sovičková; Zafar H Israili
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

4.  Serologic Detection of Anti Toxoplasma gondii Infection in Diabetic Patients.

Authors:  Shahnaz Shirbazou; Ali Delpisheh; Rahim Mokhetari; Ghafor Tavakoli
Journal:  Iran Red Crescent Med J       Date:  2013-08-05       Impact factor: 0.611

5.  Toxoplasmosis, Pancreatitis, Obesity and Drug Discovery.

Authors:  Helieh S Oz
Journal:  Pancreat Disord Ther       Date:  2014-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.